AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2022
Nov 10, 2022
284_dirs_2022-11-10_6ec5430a-ec53-4960-a1aa-956ed9917ba0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2022-11-09
Reporting Person: Oosthuizen Johannes Jacobus (President, U.S. Market)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-09 | Common Stock | S | 1795 | $103.21 | Disposed | 16730.881 | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Capital/Financing Update
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Earnings Release
2026
Apr 30